cancer

Organ-on-a-Chip Companies Revolutionize Drug Trials, Going Beyond Animal Testing In the world of pharmaceutical research and development, finding safe and...

Former Bayer R&D Chief Assumes CEO Role at BenevolentAI In a significant move for the pharmaceutical industry, Dr. Joerg Moeller,...

Understanding the Implications of Gilead’s Trodelvy Challenges and Elevation Oncology’s Unexpected Success In the world of oncology, the development and...

Correction by the Author: Investigating the Genotoxic Effects of Base and Prime Editing in Human Hematopoietic Stem Cells – A...

Salk Institute Professor Ronald Evans receives prestigious Japan Prize recognition The Salk Institute for Biological Studies is proud to announce...

Significant Proportion of European Plastic Exported to Vietnam Contributes to Environmental Pollution Plastic pollution has become a global crisis, with...

Title: FDA Warns of Rare Risk of Secondary Cancer Associated with CAR-T Therapies Introduction The U.S. Food and Drug Administration...

The Creation of a Living Biobank of Brain Metastasis Samples for Advancing Personalized Medicine Brain metastasis, the spread of cancer...

The Food and Drug Administration (FDA) has recently mandated additional cancer warnings for Chimeric Antigen Receptor T-cell (CAR-T) therapies. This...

Strand Therapeutics, a leading biotechnology company specializing in developing innovative RNA-based therapies, has recently received approval from the Food and...

Artificial intelligence (AI) has been making significant strides in various industries, and one area where its potential is particularly promising...

Gilead’s ADC Medicine Falls Short of Target in Highly Monitored Lung Cancer Study Gilead Sciences, a leading biopharmaceutical company, recently...

Cell and gene therapy have emerged as promising fields in the healthcare industry, offering potential cures for previously untreatable diseases....